Have not seen this conference call prediction yet: "Cellceutix is pleased to announce that the FDA has approved our SPA for Brilacidin ABSSSI Pivotal Phase III to move forward immediately using a portion of the proceeds from a newly formed partnership with ??." What if... So many possibilities - hope my excitement for this week's conference call is rewarded.